Filters

See more specimen types...

Other countries

Results: 1 to 20 of 27 (representing 13 labs)

Tests names and labsConditionsGenes and analytesMethods

Neurofibromatosis Type 1 and Related Disorders via the NF1 Gene

PreventionGenetics
United States
41
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Invitae Overgrowth and Macrocephaly Syndromes Panel

Invitae
United States
4320
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Paraganglioma-Pheochromocytoma Comprehensive Panel

Fulgent Genetics
United States
37111
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Sarcoma Comprehensive Panel

Fulgent Genetics
United States
92026
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Gastric Cancer Comprehensive Panel

Fulgent Genetics
United States
42414
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Breast Cancer Comprehensive Panel

Fulgent Genetics
United States
51518
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Cancer Panel

Fulgent Genetics
United States
1735124
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Pancreatic Cancer Comprehensive Panel

Fulgent Genetics
United States
61322
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hematologic Malignancy Comprehensive Panel

Fulgent Genetics
United States
53616
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Nervous System / Brain Cancer Comprehensive Panel

Fulgent Genetics
United States
83725
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Epilepsy NGS Panel

Fulgent Genetics
United States
3052447
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Congenital Heart Defects and Heterotaxy Panel

Invitae
United States
12882
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

NF1 Gene Sequencing

DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children
United States
51
  • C Sequence analysis of the entire coding region

Neurofibromatosis, Type 1

bio.logis Center for Human Genetics
Germany
41
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Single gene testing NF1

CeGaT GmbH
Germany
51
  • C Sequence analysis of the entire coding region

Neurocutaneous Panel

Molecular Vision Laboratory
United States
127
  • C Sequence analysis of the entire coding region

NF1

Fulgent Genetics
United States
51
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae RASopathies Comprehensive Panel

Invitae
United States
2718
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Paraganglioma-Pheochromocytomas NGS Panel

Fulgent Genetics
United States
3412
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Intellectual Disability NGS Panel

Fulgent Genetics
United States
752392
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 27

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center